SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 28.1 EUR 1.59% Market Closed
Market Cap: 4.2B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCHOTT Pharma AG & Co KgaA
Interest Income Expense Peer Comparison

Comparables:
E
EVT
GXI

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Interest Income Expense
€16.7m
CAGR 3-Years
68%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Interest Income Expense
-€43.1m
CAGR 3-Years
N/A
CAGR 5-Years
-33%
CAGR 10-Years
-32%
Gerresheimer AG
XETRA:GXI
Interest Income Expense
-€49.2m
CAGR 3-Years
-36%
CAGR 5-Years
-17%
CAGR 10-Years
-4%

See Also

What is SCHOTT Pharma AG & Co KgaA's Interest Income Expense?
Interest Income Expense
16.7m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Interest Income Expense amounts to 16.7m EUR.

What is SCHOTT Pharma AG & Co KgaA's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
68%

The average annual Interest Income Expense growth rates for SCHOTT Pharma AG & Co KgaA have been 68% over the past three years .

Back to Top